汉商集团股价平稳，资金流出，业绩改善但基本面承压

Group 1 - The stock price of Hanchang Group (600774) has shown relatively stable fluctuations over the past week, with a range of -0.10% and an amplitude of 4.68%. The closing price on February 13, 2026, was 9.82 yuan, with a single-day increase of 0.51% and a trading volume of 51.65 million yuan, indicating low short-term capital participation as the main capital outflow was 4.38 million yuan [1] - On February 9, 2026, a national drug procurement bidding was held, involving 316 types of chemical drugs, which may impact pricing and sales expectations in the pharmaceutical sector. Hanchang Group's main business includes chemical drug formulations, accounting for 47.74% of its operations [2] - According to the Q3 2025 financial report, Hanchang Group achieved an operating income of 764 million yuan from January to September 2025, a year-on-year decrease of 15.49%. However, the net profit attributable to shareholders increased significantly by 274.07% to 9.33 million yuan, mainly due to cost control and improvements in non-recurring income, although the overall profitability remains under pressure with a negative price-to-earnings ratio [3] Group 2 - Institutional attention towards Hanchang Group is low, with the latest sentiment being neutral and no recent research records. All institutional ratings are neutral, with no clear target price or profit forecast adjustments, indicating a lack of short-term expectations from the market [4]